Ferroptosis as a Form of Cell Death—Medical Importance and Pharmacological Implications
Pharmaceuticals · 11.08.2025 · 18 (8) · 1183
DOI: 10.3390/ph18081183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 11.08.2025. Verfasst von Blanka Kielan und 3 weiteren Autor:innen. Beteiligte Einrichtung: SUM Doctoral School, Medical University of Silesia in Katowice, 40-055 Katowice, Poland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Background/Objectives: Ferroptosis is a regulated form of cell death that occurs in the state of oxidative–antioxidative imbalance of an organism. The main components of ferroptosis are lipid peroxidation and iron accumulation. Cells experiencing ferroptosis show swelling, shrunken mitochondria with an abnormal structure, atrophic cristae, dense mitochondrial membranes, and ruptured outer membrane. Ferroptotic cells demonstrate a normal nucleus size without nuclear concentration, and neither condensation nor chromatin margination. Ferroptosis is regulated by multiple protein, genetic, and metabolic factors. The aim of this article is to present ferroptosis as a model of cell death occurring in various conditions and diseases.
Methods
A literature search of PubMed, Web of Science was performed. Search terms included “ferroptosis”, “lipid peroxidation”, “iron”, and “cell death”.
Results
Ferroptosis affects the onset, course, progression, and treatment of diseases, including neurodegenerative diseases, cancer diseases, autoimmune diseases, and hemorrhages. By using appropriate ferroptosis moderators, it is possible to influence the course of the disease in patients.
Conclusions
By understanding the ferroptosis phenomenon well, it is possible to regulate its occurrence by considering the action of oxidative and antioxidant factors. A comprehensive understanding of ferroptosis and the factors regulating this process should be the goal in therapy for many diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SUM Doctoral School, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department and Clinic of Rehabilitation Psychiatry, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
ORCID-Profile: Blanka Kielan, Artur Pałasz, Krzysztof Krysta, Marek Krzystanek
Förderung
- Medical University of Silesia
Zitieren
APA
Kielan, B., Pałasz, A., Krysta, K., & Krzystanek, M. (2025). Ferroptosis as a Form of Cell Death—Medical Importance and Pharmacological Implications. Pharmaceuticals, 18(8), 1183. https://doi.org/10.3390/ph18081183
Vancouver
Kielan B, Pałasz A, Krysta K, Krzystanek M. Ferroptosis as a Form of Cell Death—Medical Importance and Pharmacological Implications. Pharmaceuticals. 2025;18(8):1183. doi:10.3390/ph18081183
BibTeX
@article{Kielan2025,
author = {Kielan, Blanka and Pałasz, Artur and Krysta, Krzysztof and Krzystanek, Marek},
title = {Ferroptosis as a Form of Cell Death—Medical Importance and Pharmacological Implications},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {8},
pages = {1183},
doi = {10.3390/ph18081183}
}
EUVIMED